{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:07:42Z","timestamp":1786626462840,"version":"build-2736575974"},"reference-count":38,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"ICES"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["Doctoral Award \/ 201810GSD-422092"],"award-info":[{"award-number":["Doctoral Award \/ 201810GSD-422092"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["Tier 1 Canada Research Chairs"],"award-info":[{"award-number":["Tier 1 Canada Research Chairs"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To quantify well-child visits by age 2 years and developmental screening at the 18-month enhanced well-child visit among children with prenatal opioid exposure (POE) and to identify factors associated with study outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Population-based cohort study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Ontario, Canada.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>22\u2009276 children with POE born 2014\u20132018 were classified as (1) 1\u201329\u2009days of prescribed opioid analgesia, (2) 30+ days of prescribed opioid analgesia, (3) medication for opioid use disorder (MOUD), (4) MOUD and opioid analgesia, or (5) unregulated opioids.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>Attending \u22655 well-child visits by age 2 years and the 18-month enhanced well-child visit. Modified Poisson regression was used to examine factors associated with outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Children with POE to 1\u201329\u2009days of analgesics were most likely to attend \u22655 well-child visits (61.2%). Compared with these children, adjusted relative risks (aRRs) for \u22655 well-child visits were lower among those exposed to 30+ days of opioid analgesics (0.95, 95%\u2009CI 0.91 to 0.99), MOUD (0.83, 95%\u2009CI 0.79 to 0.88), MOUD and opioid analgesics (0.78 95%\u2009CI 0.68 to 0.90) and unregulated opioids (0.89, 95%\u2009CI 0.83 to 0.95). Relative to children with POE to 1\u201329\u2009days of analgesics (58.5%), respective aRRs for the 18-month enhanced well-child visit were 0.92 (95% CI 0.88 to 0.96), 0.76 (95% CI 0.72 to 0.81), 0.76 (95% CI 0.66 to 0.87) and 0.82 (95% CI 0.76 to 0.88). Having a regular primary care provider was positively associated with study outcomes; socioeconomic disadvantage, rurality and maternal mental health were negatively associated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Well-child visits are low in children following POE, especially among offspring of mothers receiving MOUD or unregulated opioids. Strategies to improve attendance will be important for child outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2022-325029","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T17:25:10Z","timestamp":1686590710000},"page":"754-761","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Prenatal opioid exposure and well-child care in the first 2 years of life: population-based cohort study"],"prefix":"10.1136","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9336-8856","authenticated-orcid":false,"given":"Andi","family":"Camden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7463-3423","authenticated-orcid":false,"given":"Teresa","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Guttmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"key":"2023081702102210000_108.9.754.1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6731a1"},{"key":"2023081702102210000_108.9.754.2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jogc.2016.11.009","article-title":"Infants born to opioid-dependent women in Ontario, 2002\u20132014","volume":"39","author":"Brogly","year":"2017","journal-title":"Journal of Obstetrics and Gynaecology Canada"},{"key":"2023081702102210000_108.9.754.3","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000208"},{"key":"2023081702102210000_108.9.754.4","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000172"},{"key":"2023081702102210000_108.9.754.5","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20160102"},{"key":"2023081702102210000_108.9.754.6","doi-asserted-by":"crossref","unstructured":"Zhao JP , Berthod C , Sheehy O , et al . Prevalence and duration of prescribed opioid use during pregnancy: a cohort study from the Quebec pregnancy cohort. BMC Pregnancy Childbirth 2021;21:800. doi:10.1186\/s12884-021-04270-x","DOI":"10.1186\/s12884-021-04270-x"},{"key":"2023081702102210000_108.9.754.7","doi-asserted-by":"crossref","unstructured":"Camden A , Ray JG , To T , et al . Prevalence of prenatal opioid exposure in Ontario, Canada, 2014-2019. JAMA Netw Open 2021;4:e2037388. doi:10.1001\/jamanetworkopen.2020.37388","DOI":"10.1001\/jamanetworkopen.2020.37388"},{"key":"2023081702102210000_108.9.754.8","doi-asserted-by":"publisher","DOI":"10.12927\/hcq.2021.26553"},{"key":"2023081702102210000_108.9.754.9","doi-asserted-by":"crossref","unstructured":"Yeoh SL , Eastwood J , Wright IM , et al . Cognitive and motor outcomes of children with prenatal opioid exposure: A systematic review and meta-analysis. JAMA Netw Open 2019;2:e197025. doi:10.1001\/jamanetworkopen.2019.7025","DOI":"10.1001\/jamanetworkopen.2019.7025"},{"key":"2023081702102210000_108.9.754.10","doi-asserted-by":"crossref","unstructured":"Gomes T , Campbell TJ , Martins D , et al . Inequities in access to primary care among opioid recipients in Ontario, Canada: A population-based cohort study. PLoS Med 2021;18:e1003631. doi:10.1371\/journal.pmed.1003631","DOI":"10.1371\/journal.pmed.1003631"},{"key":"2023081702102210000_108.9.754.11","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jogc.2017.04.028","article-title":"No.349-substance use in pregnancy","volume":"39","author":"Ordean","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"2023081702102210000_108.9.754.12","unstructured":"Riverin B , Li P , Rourke L . Evidence-Based tool for the health of infants and children from birth to age 5. Can Fam Physician Nov 2014:949\u201355."},{"key":"2023081702102210000_108.9.754.13","doi-asserted-by":"crossref","unstructured":"Goyal NK , Rohde JF , Short V , et al . Well-child care adherence after Intrauterine opioid exposure. Pediatrics 2020;145:e20191275. doi:10.1542\/peds.2019-1275","DOI":"10.1542\/peds.2019-1275"},{"key":"2023081702102210000_108.9.754.14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1377\/hlthaff.2019.00740","article-title":"Five-year outcomes among Medicaid-enrolled children with in utero opioid exposure","volume":"39","author":"Jarlenski","year":"2020","journal-title":"Health Aff (Millwood)"},{"key":"2023081702102210000_108.9.754.15","unstructured":"Ko JY , Yoon J , Tong VT . Maternal opioid exposure, neonatal abstinence syndrome, and infant healthcare utilization: a retrospective cohort analysis. Drug and Alcohol Dependence."},{"key":"2023081702102210000_108.9.754.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2016.09.006"},{"key":"2023081702102210000_108.9.754.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2014.07.013"},{"key":"2023081702102210000_108.9.754.18","doi-asserted-by":"crossref","unstructured":"Benchimol EI , Smeeth L , Guttmann A , et al . The reporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med 2015;12:e1001885. doi:10.1371\/journal.pmed.1001885","DOI":"10.1371\/journal.pmed.1001885"},{"key":"2023081702102210000_108.9.754.19","doi-asserted-by":"crossref","unstructured":"Vigod SN , Gomes T , Wilton AS , et al . Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study. BMJ 2015;350:h2298. doi:10.1136\/bmj.h2298","DOI":"10.1136\/bmj.h2298"},{"key":"2023081702102210000_108.9.754.20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/1471-0528.12567","article-title":"Maternal and newborn outcomes among women with schizophrenia: a retrospective population-based cohort study","volume":"121","author":"Vigod","year":"2014","journal-title":"BJOG: Int J Obstet Gy"},{"key":"2023081702102210000_108.9.754.21","doi-asserted-by":"crossref","unstructured":"Martins D , Singh S , Khuu W , et al . Linking the narcotics monitoring system database to quantify the contribution of prescribed and non-prescribed opioids to opioid overdoses in Ontario, Canada. IJPDS 2018;3.doi:10.23889\/ijpds.v3i4.644","DOI":"10.23889\/ijpds.v3i4.644"},{"key":"2023081702102210000_108.9.754.22","doi-asserted-by":"crossref","unstructured":"Chiu M , Lebenbaum M , Lam K , et al . Describing the linkages of the immigration, refugees and citizenship Canada permanent resident data and vital statistics death Registry to Ontario\u2019s administrative health database. BMC Med Inform Decis Mak 2016;16:135. doi:10.1186\/s12911-016-0375-3","DOI":"10.1186\/s12911-016-0375-3"},{"key":"2023081702102210000_108.9.754.23","doi-asserted-by":"crossref","unstructured":"Camden A , Ray JG , To T , et al . Identification of prenatal opioid exposure within health administrative databases. Pediatrics 2021;147:e2020018507. doi:10.1542\/peds.2020-018507","DOI":"10.1542\/peds.2020-018507"},{"key":"2023081702102210000_108.9.754.24","doi-asserted-by":"publisher","DOI":"10.46747\/cfp.6707488"},{"key":"2023081702102210000_108.9.754.25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/pch\/16.10.647","article-title":"Getting it right at 18 months: in support of an enhanced well-baby visit","volume":"16","author":"Rowan-Legg","year":"2011","journal-title":"Paediatr Child Health"},{"key":"2023081702102210000_108.9.754.26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jpeds.2020.03.016","article-title":"Implementation of a physician incentive program for 18-month developmental screening in Ontario, Canada","volume":"226","author":"Guttmann","year":"2020","journal-title":"The Journal of Pediatrics"},{"key":"2023081702102210000_108.9.754.27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.schres.2021.12.018","article-title":"Complex chronic conditions among children born to women with schizophrenia","volume":"241","author":"Toufeili","year":"2022","journal-title":"Schizophrenia Research"},{"key":"2023081702102210000_108.9.754.28","unstructured":"van Ingen T , Matheson FI . The 2011 and 2016 Iterations of the Ontario marginalization index: updates, consistency and a cross-sectional study of health outcome associations. Can J Public Health."},{"issue":"8 Suppl 2","key":"2023081702102210000_108.9.754.29","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1007\/BF03403823","article-title":"Development of the Canadian Marginalization index: a new tool for the study of inequality","volume":"103","author":"Matheson","year":"2012","journal-title":"Can J Public Health"},{"key":"2023081702102210000_108.9.754.30","unstructured":"Team MR . Mental health and addictions system performance in Ontario: a baseline Scorecard. chart pack. Toronto, Canada: Institute for Clinical Evaluative Sciences, 2018."},{"key":"2023081702102210000_108.9.754.31","doi-asserted-by":"publisher","DOI":"10.1080\/03610910902859574"},{"key":"2023081702102210000_108.9.754.32","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwh090"},{"key":"2023081702102210000_108.9.754.33","doi-asserted-by":"crossref","first-page":"e2214688","DOI":"10.1001\/jamanetworkopen.2022.14688","article-title":"Categorization of opioid use among pregnant people and association with overdose or death","volume":"5","author":"Camden","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2023081702102210000_108.9.754.34","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2012.0691"},{"key":"2023081702102210000_108.9.754.35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00127-020-01936-3","article-title":"Parental mental illness, attendance at preventive child Healthcare and dental Caries in the offspring: a nation-wide population-based cohort study","volume":"56","author":"Davidsen","year":"2021","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2023081702102210000_108.9.754.36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/pch\/pxx199","article-title":"Managing infants born to mothers who have used opioids during pregnancy","volume":"23","author":"Lacaze-Masmonteil","year":"2018","journal-title":"Paediatr Child Health"},{"key":"2023081702102210000_108.9.754.37","doi-asserted-by":"crossref","unstructured":"Patrick SW , Barfield WD , Poindexter BB , et al . Neonatal opioid withdrawal syndrome. Pediatrics 2020;146:e2020029074. doi:10.1542\/peds.2020-029074","DOI":"10.1542\/peds.2020-029074"},{"key":"2023081702102210000_108.9.754.38","doi-asserted-by":"crossref","first-page":"951","DOI":"10.15585\/mmwr.mm6929a2","article-title":"Identification of Substance-Exposed Newborns and Neonatal Abstinence Syndrome Using ICD-10-CM - 15 Hospitals, Massachusetts, 2017","volume":"69","author":"Goyal","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2022-325029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T09:13:13Z","timestamp":1692263593000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2022-325029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,8,17]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1136\/archdischild-2022-325029"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2022-325029","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,12]]}}}